cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.22611508.v1
title: Additional file 7 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 7. sTable 6 Trend in prevalence of obesity among US adults from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611511
title: Additional file 8 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 8. sTable 7 Trend in prevalence of elevated blood pressure among US adults from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611517
title: Additional file 10 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 10. sTable 9 Change in the distribution of characteristics among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611496.v1
title: Additional file 3 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 3. sTable 2 Annual prevalence change of metabolic syndrome and components among US adults, 1999–20,118.
DOI: 10.6084/m9.figshare.22611511.v1
title: Additional file 8 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 8. sTable 7 Trend in prevalence of elevated blood pressure among US adults from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611463.v1
title: Additional file 4 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 4: Table S4. (A–F) Genetical discrepancies between SPLC and sMPLc patients.
DOI: 10.6084/m9.figshare.13103258
title: Arctic COSMO-CLM hindcast 1990

description: COSMO-CLM Russian Arctic climate dataset
DOI: 10.6084/m9.figshare.22611466.v1
title: Additional file 5 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 5: Table S5. (A–I) Genetical discrepancies between SPLC and sMPLc patients.
DOI: 10.6084/m9.figshare.22611544.v1
title: Additional file 19 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 19. sTable 18 Trend in treatment of blood pressure lowering medication among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611469
title: Additional file 6 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 6: Table S6. (A) KEGG analysis results in sMPLC. (B) KEGG analysis results in SPLC.
DOI: 10.6084/m9.figshare.22611532.v1
title: Additional file 15 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 15. sTable 14 Change in distribution of characteristics among elevated blood pressure from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611538.v1
title: Additional file 17 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 17. sTable 16 Trend in treatment of blood-lipid regulated medication among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.13103258.v7
title: Arctic COSMO-CLM hindcast 1990

description: COSMO-CLM Russian Arctic climate dataset
DOI: 10.6084/m9.figshare.22611514
title: Additional file 9 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 9. sTable 8 Prevalence of metabolic syndrome and components among US adults from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611514.v1
title: Additional file 9 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 9. sTable 8 Prevalence of metabolic syndrome and components among US adults from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611553
title: Additional file 22 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 22. sTable 21 Trend in control rate of weight status among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611541
title: Additional file 18 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 18. sTable 17 Trend in intervention of physical activity among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611556.v1
title: Additional file 23 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 23. sTable 22 Trend in control rate of blood pressure among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22606529
title: Additional file 6 of Non-CpG sites preference in G:C &gt; A:T transition of TP53 in gastric cancer of Eastern Europe (Poland, Romania and Hungary) compared to East Asian countries (China and Japan)

description: Additional file 6: Table S1. Primers for PCR amplification of TP53 gene. Table S2. Histological type and TP53 mutation status. Table S3. Mutation distribution in TP53 (exon 4–8). Table S4. Mutation functions of TP53 (exon 4-8) in Eastern Europe, China and Japan. Table S5. Mutation spectrum of TP53 (exon 4–8) in Eastern Europe, China and Japan. Table S6. Hotspot mutation in Eastern Europe, China and Japan.
DOI: 10.6084/m9.figshare.22611457
title: Additional file 2 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 2: Table S2. Tumor mutation burden in SPLC and sMPLC patients.
DOI: 10.6084/m9.figshare.22611457.v1
title: Additional file 2 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 2: Table S2. Tumor mutation burden in SPLC and sMPLC patients.
DOI: 10.6084/m9.figshare.22611460
title: Additional file 3 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 3: Table S3. (A) Gene mutation landscape in SPLC patients—gender-oriented. (B) Gene mutation landscape in SPLC patients—age-oriented. (C) Gene mutation landscape in SPLC patients—nodule size-oriented. (D) Gene mutation landscape in SPLC patients—CT feature-oriented. (E) Gene mutation landscape in SPLC patients—histology-oriented. (F) Gene mutation landscape in sMPLC patients—gender-oriented. (G) Gene mutation landscape in sMPLC patients—age-oriented. (H) Gene mutation landscape in sMPLC patients—nodule size-oriented. (I) Gene mutation landscape in sMPLC patients—CT feature-oriented. (J) Gene mutation landscape in sMPLC patients—histology-oriented.
DOI: 10.6084/m9.figshare.22611466
title: Additional file 5 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 5: Table S5. (A–I) Genetical discrepancies between SPLC and sMPLc patients.
DOI: 10.6084/m9.figshare.22611532
title: Additional file 15 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 15. sTable 14 Change in distribution of characteristics among elevated blood pressure from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611550.v1
title: Additional file 21 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 21. sTable 20 Trend in control rate of triglyceride among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611454
title: Additional file 1 of Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer

description: Additional file 1: Table S1. (A) Clinical characteristics of all the patients. (B) Clinical characteristics of the patient for genome-wide DNA methylation and RNA-seq analyses.
DOI: 10.6084/m9.figshare.22611526.v1
title: Additional file 13 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 13. sTable 12 Change in distribution of characteristics among elevated triglyceride from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611529
title: Additional file 14 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 14. sTable 13 Change in distribution of characteristics among obesity from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611538
title: Additional file 17 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 17. sTable 16 Trend in treatment of blood-lipid regulated medication among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611544
title: Additional file 19 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 19. sTable 18 Trend in treatment of blood pressure lowering medication among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22606559.v1
title: Additional file 1 of Risk factors for early neurologic deterioration in single small subcortical infarction without carrier artery stenosis: predictors at the early stage

description: Additional file 1.
DOI: 10.6084/m9.figshare.22606589
title: Additional file 1 of Midwife empathy and its association with the childbirth experience: a cross-sectional study

description: Additional file 1.
DOI: 10.6084/m9.figshare.22611535
title: Additional file 16 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 16. sTable 15 Trend in treatment of glucose lowering medication among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.22611556
title: Additional file 23 of Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018

description: Additional file 23. sTable 22 Trend in control rate of blood pressure among metabolic syndrome from 1999 to 2018.
DOI: 10.6084/m9.figshare.11391294.v1
title: Vestibular implant: does it really work? A systematic review

description: Abstract Introduction: People with vestibular loss present a deficit in the vestibular system, which is primarily responsible for promoting postural control, gaze stabilization, and spatial orientation while the head moves. There is no effective treatment for a bilateral loss of vestibular function. Recently, a vestibular implant was developed for people with bilateral loss of vestibular function to improve this function and, consequently, the quality of life of these patients. Objective: To identify in the scientific literature evidence that vestibular implants in people with vestibular deficit improves vestibular function. Methods: One hundred and forty six articles were found from five databases and 323 articles from the gray literature mentioning the relationship between vestibular implant and vestibular function in humans. The PICOS strategy (Population, Intervention, Comparison and Outcome) was used to define the eligibility criteria. The studies that met the inclusion criteria for this second step were included in a qualitative synthesis, and each type of study was analyzed according to the bias risk assessment of the Joanna Briggs Institute through the critical assessment checklist Joanna Briggs institute for quasi-experimental studies and the Joanna Briggs institute critical assessment checklist for case reports. Results: Of the 21 articles included in reading the full text, 10 studies were selected for the qualitative analysis in the present systematic review. All ten articles analyzed through the critical assessment checklist Joanna Briggs institute showed a low risk of bias. The total number of samples in the evaluated articles was 18 patients with vestibular implants. Conclusions: Taken together, these findings support the feasibility of vestibular implant for restoration of the vestibulo-ocular reflex in a broad frequency range and illustrate new challenges for the development of this technology.
DOI: 10.6084/m9.figshare.11391294
title: Vestibular implant: does it really work? A systematic review

description: Abstract Introduction: People with vestibular loss present a deficit in the vestibular system, which is primarily responsible for promoting postural control, gaze stabilization, and spatial orientation while the head moves. There is no effective treatment for a bilateral loss of vestibular function. Recently, a vestibular implant was developed for people with bilateral loss of vestibular function to improve this function and, consequently, the quality of life of these patients. Objective: To identify in the scientific literature evidence that vestibular implants in people with vestibular deficit improves vestibular function. Methods: One hundred and forty six articles were found from five databases and 323 articles from the gray literature mentioning the relationship between vestibular implant and vestibular function in humans. The PICOS strategy (Population, Intervention, Comparison and Outcome) was used to define the eligibility criteria. The studies that met the inclusion criteria for this second step were included in a qualitative synthesis, and each type of study was analyzed according to the bias risk assessment of the Joanna Briggs Institute through the critical assessment checklist Joanna Briggs institute for quasi-experimental studies and the Joanna Briggs institute critical assessment checklist for case reports. Results: Of the 21 articles included in reading the full text, 10 studies were selected for the qualitative analysis in the present systematic review. All ten articles analyzed through the critical assessment checklist Joanna Briggs institute showed a low risk of bias. The total number of samples in the evaluated articles was 18 patients with vestibular implants. Conclusions: Taken together, these findings support the feasibility of vestibular implant for restoration of the vestibulo-ocular reflex in a broad frequency range and illustrate new challenges for the development of this technology.
DOI: 10.6084/m9.figshare.12056556
title: Cross-cultural adaptation of the Amsterdam inventory for auditory disability and handicap to Brazilian Portuguese

description: Abstract Introduction Patient-reported outcome measures, inventory and or questionnaire, allow patients to present their perspective of the impact of their individual condition on a day-to-day basis, independent of the analysis of test results by the expert clinician. Outcome measures are recommended when there is evidence showing their reliability, validity and sensitivity. There are standardized patient-reported outcome measures for hearing in English language; however, other languages lack these instruments. Objective Adapt the Amsterdam inventory for auditory disability and handicap to Brazilian Portuguese and analyze its validation measures. Methods We conducted two studies. In Study 1, we translated and adapted the Amsterdam inventory for auditory disability and handicap to Brazilian Portuguese according to good practice guidelines; this included the pre-test stage. In Study 2, we administered the Portuguese version to adults with and without hearing loss (n = 31 and 18, respectively) and analyzed the measures of instrument validation, reliability, and reproducibility. Moreover, we calculated the correlation between pure tone thresholds and scores on the questionnaire. Results The results obtained in Study 1 demonstrated the feasibility of the translation process and the instrument's cultural adaptation, as well as its applicability, resulting in the Portuguese version of the Amsterdam inventory for auditory disability and handicap. In Study 2, the results revealed construct values for the questions and domains, as well as for the total reliable score. The intra-interviewer test-retest condition showed excellent reproducibility (ICC = 0.97). Finally, there was a strong positive correlation (r = 0.83) between the mean pure tone threshold and the hearing difficulties values, as measured by the instrument's scores. Conclusion The English version of the Amsterdam inventory for auditory disability and handicap could be translated and adapted to Brazilian Portuguese. An analyses of the validation process yielded reliable, consistent, and stable results.
DOI: 10.6084/m9.figshare.12056556.v1
title: Cross-cultural adaptation of the Amsterdam inventory for auditory disability and handicap to Brazilian Portuguese

description: Abstract Introduction Patient-reported outcome measures, inventory and or questionnaire, allow patients to present their perspective of the impact of their individual condition on a day-to-day basis, independent of the analysis of test results by the expert clinician. Outcome measures are recommended when there is evidence showing their reliability, validity and sensitivity. There are standardized patient-reported outcome measures for hearing in English language; however, other languages lack these instruments. Objective Adapt the Amsterdam inventory for auditory disability and handicap to Brazilian Portuguese and analyze its validation measures. Methods We conducted two studies. In Study 1, we translated and adapted the Amsterdam inventory for auditory disability and handicap to Brazilian Portuguese according to good practice guidelines; this included the pre-test stage. In Study 2, we administered the Portuguese version to adults with and without hearing loss (n = 31 and 18, respectively) and analyzed the measures of instrument validation, reliability, and reproducibility. Moreover, we calculated the correlation between pure tone thresholds and scores on the questionnaire. Results The results obtained in Study 1 demonstrated the feasibility of the translation process and the instrument's cultural adaptation, as well as its applicability, resulting in the Portuguese version of the Amsterdam inventory for auditory disability and handicap. In Study 2, the results revealed construct values for the questions and domains, as well as for the total reliable score. The intra-interviewer test-retest condition showed excellent reproducibility (ICC = 0.97). Finally, there was a strong positive correlation (r = 0.83) between the mean pure tone threshold and the hearing difficulties values, as measured by the instrument's scores. Conclusion The English version of the Amsterdam inventory for auditory disability and handicap could be translated and adapted to Brazilian Portuguese. An analyses of the validation process yielded reliable, consistent, and stable results.
DOI: 10.6084/m9.figshare.12056820
title: Anatomical study of jugular foramen in the neck

description: Abstract Introduction The anatomical complexity of the jugular foramen makes surgical procedures in this region delicate and difficult. Due to the advances in surgical techniques, approaches to the jugular foramen became more frequent, requiring improvement of the knowledge of this region anatomy. Objective To study the anatomy of the jugular foramen, internal jugular vein and glossopharyngeal, vagus and accessory nerves, and to identify the anatomical relationships among these structures in the jugular foramen region and lateral-pharyngeal space. Methods A total of 60 sides of 30 non-embalmed cadavers were examined few hours after death. The diameters of the jugular foramen and its anatomical relationships were analyzed. Results The diameters of the jugular foramen and internal jugular vein were greater on the right side in most studied specimens. The inferior petrosal sinus ended in the internal jugular vein up to 40 mm below the jugular foramen; in 5% of cases. The glossopharyngeal nerve exhibited an intimate anatomical relationship with the styloglossus muscle after exiting the skull, and the vagal nerve had a similar relationship with the hypoglossal nerve. The accessory nerve passed around the internal jugular vein via its anterior wall in 71.7% of cadavers. Conclusion Anatomical variations were found in the dimensions of the jugular foramen and the internal jugular vein, which were larger in size on the right side of most studied bodies; variations also occurred in the trajectory and anatomical relationships of the nerves. The petrosal sinus can join the internal jugular vein below the foramen.
DOI: 10.6084/m9.figshare.12056820.v1
title: Anatomical study of jugular foramen in the neck

description: Abstract Introduction The anatomical complexity of the jugular foramen makes surgical procedures in this region delicate and difficult. Due to the advances in surgical techniques, approaches to the jugular foramen became more frequent, requiring improvement of the knowledge of this region anatomy. Objective To study the anatomy of the jugular foramen, internal jugular vein and glossopharyngeal, vagus and accessory nerves, and to identify the anatomical relationships among these structures in the jugular foramen region and lateral-pharyngeal space. Methods A total of 60 sides of 30 non-embalmed cadavers were examined few hours after death. The diameters of the jugular foramen and its anatomical relationships were analyzed. Results The diameters of the jugular foramen and internal jugular vein were greater on the right side in most studied specimens. The inferior petrosal sinus ended in the internal jugular vein up to 40 mm below the jugular foramen; in 5% of cases. The glossopharyngeal nerve exhibited an intimate anatomical relationship with the styloglossus muscle after exiting the skull, and the vagal nerve had a similar relationship with the hypoglossal nerve. The accessory nerve passed around the internal jugular vein via its anterior wall in 71.7% of cadavers. Conclusion Anatomical variations were found in the dimensions of the jugular foramen and the internal jugular vein, which were larger in size on the right side of most studied bodies; variations also occurred in the trajectory and anatomical relationships of the nerves. The petrosal sinus can join the internal jugular vein below the foramen.